HK1237262B - 免疫球蛋白g制品的皮内施用 - Google Patents

免疫球蛋白g制品的皮内施用 Download PDF

Info

Publication number
HK1237262B
HK1237262B HK17111170.0A HK17111170A HK1237262B HK 1237262 B HK1237262 B HK 1237262B HK 17111170 A HK17111170 A HK 17111170A HK 1237262 B HK1237262 B HK 1237262B
Authority
HK
Hong Kong
Prior art keywords
igg
composition
administration
treatment
immunodeficiency
Prior art date
Application number
HK17111170.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1237262A1 (zh
Inventor
Vikram Arora
Ralph Christian Crumrine
Kristine Bergstrand
Hongbin Li
Todd W. Willis
Original Assignee
Grifols Worldwide Operations Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Worldwide Operations Limited filed Critical Grifols Worldwide Operations Limited
Publication of HK1237262A1 publication Critical patent/HK1237262A1/zh
Publication of HK1237262B publication Critical patent/HK1237262B/zh

Links

HK17111170.0A 2016-02-05 2017-11-01 免疫球蛋白g制品的皮内施用 HK1237262B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662292075P 2016-02-05

Publications (2)

Publication Number Publication Date
HK1237262A1 HK1237262A1 (zh) 2018-04-13
HK1237262B true HK1237262B (zh) 2023-04-14

Family

ID=

Similar Documents

Publication Publication Date Title
BERGER et al. Immunoglobulin replacement therapy by slow subcutaneous infusion
ES2983475T3 (es) Métodos para mejorar la eficacia de una vacuna mediante la administración de un antagonista de IL-4R
ES2339236T3 (es) Administracion de fragmentos de anticuerpo f(ab')2 anti-tnf-alfa.
JP6762877B2 (ja) 熱ショックタンパク質を本質的に含まない医薬製剤、医薬製剤を含むバイアル又は投与具、バイアル又は投与具を含むキット、並びにアレルギーの治療方法
US20250122270A1 (en) Intradermal administration of immunoglobulin g preparation
Ashida et al. Home intravenous immunoglobulin therapy by self-administration
JP2019521156A5 (zh)
Roberts et al. Intraperitoneal voriconazole in a patient with Aspergillus peritoneal dialysis peritonitis
So Improving patient compliance with biopharmaceuticals by reducing injection-associated pain
HK1237262B (zh) 免疫球蛋白g制品的皮内施用
HK1237262A1 (zh) 免疫球蛋白g制品的皮内施用
BR102017000820B1 (pt) Administração intradérmica de preparação de imunoglobulina g
BR102017000820A2 (pt) Intradérmic administration of immunoglobulin g preparation
WO2022089417A1 (zh) 一种用于治疗脊柱与骨关节病变并减轻其疼痛的药物及其应用
JP7621411B2 (ja) 慢性炎症性脱髄性多発神経炎の治療における使用のための免疫グロブリン製品
US20250034280A1 (en) Method and apparatus for using omalizumab
AU2005200643B2 (en) Oil-in-water emulsion for the use as medicament or for producing a medicament
RU2666942C1 (ru) Способ лечения полинейромиопатии критических состояний у реанимационных больных
Hill et al. Coversin, a novel C5 complement inhibitor, for the treatment of PNH: results of a Phase 2 clinical trial
Aschenbrenner New Drug for Atopic Dermatitis
CN117897173A (zh) 含有2019新型冠状病毒抗体的药物制剂
Sani et al. Comparison of low dose intradermal with high dose intramuscular hepatitis B vaccination in hemodialysis patients
Saba Rassouli What Is SCIG?
RUTLEDGE Resuming Infliximab Seems Safe, Effective in AS
Ermitano et al. 530 Successful treatment of extensive chronic leg ulcer with recombinant human granulocyte-macrophage colony stimulating factor (rhuGM-CSF) in a patient with commmon variable immune deficiency (CVID)